CCR2 and Cirrhosis: The inhibition of CCR2+ monocyte recruitment shows potential to improve fibrosis in patients with NASH (Krenkel et al., 2018), but needs further evaluation for the potential of cirrhosis reversibility and its effect on cirrhosis due to other underlying liver diseases.